The ISN-ACT Global Trials Focus team has collected and published a new list of randomized research from nephrologists around the world for August 2020. Each trial is reviewed in context and the risk of bias in seven key areas is assessed. Highlight: Allopurinol does not slow the progression of chronic kidney disease in patients with type 1...
The full DAPA-CKD trial results will be presented and reviewed at the ESC Congress 2020, Sunday, August 30, 17:00 – 17:30 CET. Topic Renal failure and Cardiovascular Disease Chairpersons Rory Collins (Oxford, UK); Frank Ruschitzka (Zurich, Switzerland) Presentations: DAPA-CKD – Dapagliflozin in Patients with CKD: Hiddo Heerspink (Groningen, Netherlands) DAPA- CKD – Live Prime Discussion: Diederick E Grobbee (Utrecht, Netherlands) Q&A Session The...
The ISN will contribute to a panel discussion, « A Global Perspective on Kidney Failure” at the Innovations in Dialysis Expediting Advances Symposium (IDEAS) on August 31, 2020. Representing the ISN on the panel are: Vivekanand Jha, Executive Director at The George Institute for Global Health, India, Chair of Global Kidney Health, Imperial College of London, President, International Society of Nephrology (ISN) and Aminu Bello, Professor of Medicine, University of...
The ISN invites nephrologists to register patients affected by COVID-19 on the new global COVID registry. The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection. For more information, please visit...
Kidney International will shortly publish the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020, developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, in early 2020. This is the first attempt by the international nephrology community to identify reproducible,...
The ISN invites members to register patients affected by COVID on the new global COVID registry. The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection. The initiative was led...
Stefaan Claus, RN Nephrology Division, Ghent University Hospital, Ghent, Belgium Member of the ISN Kidney Health Professionals Working Group In October 2019, the ISN organized a Continuing Nurse Education (CNE) program at the Kenyatta University Hospital Nairobi, Kenya. One year earlier, in 2018, Professor Marie Richards, along with the local nurses in the renal unit and the heads...
The ISN and Asian Pacific Society of Nephrology (APSN) have sustained a successful collaboration over the last decade, working together to advance kidney care in the Asia-Pacific region. The ISN is pleased to share with members that the APSN’s 18th Asian Pacific Congress of Nephrology (APCN) will take place from 2-4 October 2020 at the Hong...
Young ISN members from Bangladesh, Ghana, and Brazil reflect on their experiences on the frontline of the COVID-19 pandemic. Read reflections from other young ISN members here. Find resources relating to the COVID-19 infection here. Reflections from Dhaka Tania Mahbub, Consultant Nephrologist, ISN Fellow, United Hospital Limited, Dhaka, Bangladesh Since it is a novel disease, the modus operandi of COVID-19 management has...
Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world. Highlight: Early ACE-inhibition is safe in pediatric Alport’s Syndrome and may be effective See the latest trials here
The ISN, in collaboration with the Mario Negri Institute for Pharmacological Research, will hold the ISN 2021 Frontiers Meeting on ‘Complement-related kidney diseases: classification, genetics, and treatment’ from July 1-3, in Bergamo, Italy. This specialist meeting will focus on the two prototypical complement-mediated kidney diseases: atypical hemolytic uremic syndrome (aHUS), and C3 Glomerulopathies/Membranoproliferative Glomerulonephritis (C3G/MPGN),...
How does the ISN meet the challenge of presenting the latest complex ideas in easy-to-understand nuggets of information? Discover the @ISNeducation Social Media Team and the ISN WCN Social Media Team. ISN WCN Social Media Team Over the past decade, Social Media (SoMe) platforms have become increasingly popular to disseminate information from medical conferences. Twitter has become...
ISN members may access the ISN-ACT (advancing clinical trials) Patient Engagement Working Group’s article, “International Perspectives on Patient Involvement in Clinical Trials in Nephrology,” published in KI on 9 July 2020. The article highlights the important need to improve patient involvement in clinical trials to promote high-quality research in nephrology. It describes also the current challenges...
In Episode 4 of the ISN Global Kidney Care Podcast (GKCP) series, the hosts converse with Hernando Trujillo and Angel Sevillano (Hospital Universitario 12 de Octubre in Madrid, Spain) authors of the Kidney International Reports article, “SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease.” The discussion considers the findings in the article and explores the professional and personal struggles...
Stay connected in uncertain times. Hosted by the Canadian Society of Nephrology (CSN) and la Société Québécoise de Néphrologie (SQN), WCN’21 remains scheduled from April 15-18, 2021 in Montreal, Canada The far-reaching consequences of the COVID-19 pandemic will continue to impact the way we share knowledge. The ISN is adjusting to this reality and is closely monitoring developments and following...
Due to its timeliness, Seminars in Nephrology has made the current issue, Nephrology and Social Media, fully available to the public. This issue focuses on the way medical professionals (#medtwitter) use Twitter and analyzes Twitter's role as a new tool for learning, teaching, networking, professional development, mentorship, sponsorship, and advocacy within medicine. The edition examines the principles of adult...
ISN Educational Ambassador, Nitin Kolhe, consultant nephrologist at the University of Derby and Burton (UHDB) NHS Foundation Trust in the United Kingdom, spent a week at Mpilo Central Hospital in Bulawayo, Zimbabwe as part of the ISN Educational Ambassadors Program (EAP) in March 2020, before COVID-19 restrictions were in place. UHDB nurses Sister Carol Rhodes and Sister...
The International Society of Nephrology urges all investigators and industry partners to include people with kidney diseases in research activities related to COVID-19. The ISN-ACT (Advancing Clinical Trials) Committee has released a statement on the urgent need to include patients with kidney diseases in clinical trials related to COVID-19. Despite preliminary studies demonstrating the increased risk...
The COVID-19 pandemic is likely to disproportionately impact people living with kidney disease. It is, therefore, more important than ever to monitor the care being delivered to patients with kidney diseases and to use data to advocate for those at risk of adverse outcomes. Recognizing this, the ISN has launched several data collection initiatives over the past few...
Founding papers on current nephrology: from acute kidney injury to diabetic kidney disease As part of ISN’s 60th-anniversary, Kidney International’s “Milestones in Nephrology” series highlights five significant contributions to acute kidney injury, diabetic kidney disease, and cell biology: Glomerular hemodynamics in experimental diabetes mellitus (Hostetter TH, Troy JL, Brenner BM, 1981) Effect of intensive therapy on the development...
